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The early recognition of jaundice type remains s t i l l an unsolved problem. 
The differentiation between cholestatic and other icterus forms as wel l as between 
intra- and extrahepatic cholestasis presents one rather difficult and complicated 
task in everyday c l in ica l practice. Th i s fact warrants the extended c l i n i ca l and 
experimental investigations as we l l as the recent introduction of a number of 
laboratory tests. 
Cholestasis is accompanied by various metabolic abnormalities. The distur­
bances of l ip id metabolism are the most severe ones. Some interesting changes of 
the lipoprotein ( L P ) level — a significant be ta-LP increase (up to 100 per cent) 
as wel l as a decrease t i l l a complete a lpha -LP absence can be found out. 
I n 1969 Seidel and Alauporic (cited after 2, 3) described a pathological L P 
occurring in the plasma during cholestasis which they called L P - Х . I t s re la t ive 
density is low (1,006—1,063 g/ml) but L P - Х is quite different from this normal 
class of low-density lipoproteins ( L D L ) ( 1 , 2, 3, 8, 9, 11). According to its compo­
sit ion L P - Х differs also from other normal L P classes. I t is r i ch in phospholipids 
(mainly lecithin) and more than 90 per cent of its cholesterol is non-esterified. 
I t contains traces of triglycerides and a few of bile acids (3 per cent) only. The 
unsaturated fatty acids contents of its phospholipids is much smaller than that of 
normal L P . LJ?-X protein part which is mainly presented by both albumin (40 per 
cent) and apoprotein С is about 3 times smaller than that of normal L D L (2, 3, 4, 
5, 7, 10). 
The considerable differential-diagnostic significance of L P - Х in jaundice is 
due to its very high cholestatic specificity. I t is re la t ive ly early positive in cho­
lestasis patients' serum (2, 3) . I t can be established in both intra- and extrahepa­
tic cholestasis and possesses, therefore, no differential-diagnostic value i n these 
cholestatic forms (12, 13). On the other hand, extrahepatic cholestasis can induce 
a secondary parenchymatous dystrophy (10). 
The purpose of the present study is the investigation of the diagnostic value 
of L P - Х in some cholestasis diseases. 
Material and methods 
Serum L P - Х was determined in 108 patients w i t h 8 various cholestasis d i ­
seases. There were 72 males agsd between 35 and 83 years, mean age 64 years, 
and 36 females aged between 19 and 78 years, mean age 57 years. The pr imary 
disease which had caused cholestasis or even cholestasis syndrome was established 
by using routine clinico-laboratory tests as we l l as some contemporary instrumen­
tal-apparatus methods such as echography, scintigraphy, laparoscopy, endosco­
pic retrograde cholecystopancreatography, percutaneous transhepatic cholangio-
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graphy, laparotomy, e t c L P - Х was determined by using an agar electrophoretic 
semiquantitative Seidel 's method followed by L P precipitation wi th magnesium 
heparin solution. 
Results and discussion 
The results received are given on table 1. Most patients are wi th chole l i th ia" 
sis-choledochlithiasis. L P - Х appears in 92,85 per cent of them. However, it is ab-
T a b l e 1 
Cholestatic diseases and LP-Х presence in different diseases 
Disease 
L P - X 
% positive 
1. Cholelithiasis — 
Choledocholithiasis 
2. Pancreas head cancer 
3. L iver cancer 
4. Liver cirrhosis 
with intrahepatic 
cholestasis 
5. Chronic active hepatitis 
cholestatic form 
6. Acute alcoholic 
hepatitis 
7. Recidivans jaundice 
of pregnancy 
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sent in 3 patients probably due to low-gradual hyperbi l i rubinaemia (serum b i l i ­
rubin level up to 3 mg % ) . I n two patients (10 per cent) w i t h pancreas head cancer 
L P - Х was also absent although there was a severe cholestasis — in the first pa­
tient serum bi l i rubin level was 16 mg % and in the second one even 33 mg % . 
The patients wi th l iver cirrhosis had well-expressed cl inico-chemical chole­
stasis indexes. Tha t ' s why L P - Х was observed in a re la t ive ly high percentage 
wi th these patients. I t is noteworthy that LP-Х was present in a l l the patients 
w i th cholestatic form of chronic active hepatitis. The acute alcoholic hepatitis 
is manifested on the ground of preceeding chronic alcoholic cholestatic hepato-
pathy. L P - Х presence was estimated in 100 per cent of the patients w i th recidive 
jaundice of pregnancy and wi th cholestatic form of an acute v i r a l hepatitis. L P - X 
was found out in a total of 91,67 per cent of cholestasis patients independently 
on the causative disease. 
We can conclude that L P - X detection is a promising method in cholestasis 
diagnostics although it does not make it possibly to estimate the cause and cha­
racter of cholestasis proper. The differential diagnosis between intra-and ex-
trahepatic cholestasis is a difficult problem which could not be solved by using 
L P - X , indeed. 
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ЛИПОПРОТЕИН-Х И ЕГО ЗНАЧЕНИЕ ДЛЯ ЛЕЧЕНИЯ 
БОЛЬНЫХ ХОЛЕСТАЗОМ 
i 
Г . Варбанов, Р . Патева 1 
Р Е З Ю М Е 
Изучена диагностическая ценность ЛП-Х при восьми заболеваниях, протекающих с 
холестазом у 108 больных. Независимо от основного заболевания, почти у всех больных 
(в 91 % случаев) было установлено наличие Л П - Х . 
Установление ЛП-Х является надеждным методом диагностики холестаза, независимо 
от того, что этот метод не дает возможность судить о причине и характере холестаза. Диффе­
ренциальный диагноз йнтра- и экстрагепатального холестаза не удается легко. ) 
Авторами сделан вывод, что для определения типа холестаза ЛП-Х не имеет значения. 
